Spectrum, Investors Get Preliminary OK Of $7M Settlement
A Nevada federal judge on Tuesday preliminarily approved a $7 million settlement between Spectrum Pharmaceuticals Inc. and a class of shareholders accusing the company of not properly disclosing that a generic...To view the full article, register now.
Already a subscriber? Click here to view full article